Muscle, wasting/atrophy NOS: Difference between revisions
No edit summary |
|||
| Line 18: | Line 18: | ||
* Sarcopenia-age related progressive loss of muscle mass and strength | * Sarcopenia-age related progressive loss of muscle mass and strength | ||
* To code muscle weakness due to an active Covid infection, where this is the only evidence of the infection, use codes: [[Muscle, wasting/atrophy NOS]], with [[COVID-19 (SARS-COV-2)]], and [[Carrier of infectious disease, unspecified]] | * To code muscle weakness due to an active Covid infection, where this is the only evidence of the infection, use codes: [[Muscle, wasting/atrophy NOS]], with [[COVID-19 (SARS-COV-2)]], and [[Carrier of infectious disease, unspecified]] | ||
'''Excludes''' | |||
* [[Critical illness polyneuropathy (peripheral)|Critical illness polyneuropathy]] | |||
{{ICD10 Acquired neuromuscular weakness}} | {{ICD10 Acquired neuromuscular weakness}} | ||